Letter from the Editors

  • Editorial Office
Keywords: Journal, Rare Diseases, Orphan Drugs


Last year we successfully introduced a new journal: The Journal of Rare Diseases and Orphan Drugs (JRDOD) is a peer-reviewed open-access medical journal that publishes original research, reviews, case reports, and letters covering a broad field of its specialty. We intend to publish articles stimulating to read, educate, and inform readers with the most up-to-date research in genetics, rare diseases, and new orphan drug development in different stages of clinical trials. Journal topics are centered on patients living with undiagnosed rare diseases, the importance of a diagnosis, individual approaches to treatments. We hope that this journal will increase awareness of many difficult to diagnosed and treat medical conditions.


1. Haffner M.E. Adopting orphan drugs--two dozen years of treating rare diseases. N Engl J Med. 2006; 354: 445-447
2. Orphan Drug Act. 2049 – 2066. Available from: http://www.gpo.gov/fdsys/granule/STATUTE-96/STATUTE-96-Pg2049/content-detail.htm. [Accessed October 20, 2020].
3. Rare diseases and orphan products: accelerating research and development. Available from: http://www.nap.edu/catalog.php?record_id=12953. [Accessed October 20, 2020].
4. https://www.govinfo.gov/content/pkg/PLAW-107publ280/html/PLAW-107publ280.htm. [Accessed October 20, 2020].
5."Genetic and Rare Diseases Information Center". National Center for Advancing Translational Sciences, US National Institutes of Health. 2019. Retrieved 12 October 2019.
How to Cite
Office, E. (2020). Letter from the Editors. Journal of Rare Diseases and Orphan Drugs, 2, 1. https://doi.org/10.36013/jrdod.v2i.33